그림 16. 피인용 수에 따른 특허 수의 분포
| ○ | 오가노이드 기술에 속하는 특허 26777편 중 (2019-2024년 출판된 특허), 적어도 1회 이상 인용된 특허 수는 6952편(25.96%)임. |
| ○ | 오가노이드 기술에 속하는 특허 중 피인용수가 높은 특허 리스트를 표 18 에 나타내었음. |
표 18. 고 피인용 특허 목록
| 번호 | 특허제목(미국특허번호) | 출원인 | 패밀리 특허번호 | 피인용 수 |
|---|---|---|---|---|
| 1 | Methods and systems for processing polynucleotides (10550429) |
10X GENOMICS, INC.(US, CA, Pleasanton) | US 11248267 B2 20220215; US 2021189484 A1 20210624; US 2022177962 A1 20220609; US 2022307082 A1 20220929; US 2022349003 A1 20221103; US 10550429 B2 20200204; US 2019338353 A1 20191107; US 10793905 B2 20201006; US 2020140944 A1 20200507; US 10954562 B2 20210323; US 2020216897 A1 20200709 | 99 |
| 2 | Soybean event MON89788 and methods for detection thereof (10738320) |
MONSANTO TECHNOLOGY LLC(US, MO, St. Louis) | US 10738320 B2 20200811; US 2020017874 A1 20200116; US 11390881 B2 20220719; US 2021017535 A1 20210121; US 2022389441 A1 20221208; US 2023159947 A1 20230525; US 2019185876 A1 20190620; US 2019185875 A1 20190620; CL 2013002676 A1 20140307; CL 2013002680 A1 20140307; CL 2013002678 A1 20140307; US 9944945 B2 20180417; US 2015113686 A1 20150423; EP 2975129 A1 20160120; IN 9378DE2007 A 20080627; ES 2603857 T3 20170301; PT 1885176 T 20161128; HK 1220721 A1 20170512; SG 138646 A1 20080229; US 2017156276 A1 20170608; US 10273498 B2 20190430; HK 1153232 A1 20120323; PH 12007502677 B1 20140813; AU 2011201461 B2 20110915; AU 2011201461 A1 20110421; US 9017947 B2 20150428; US 2012070839 A1 20120322; SG 179442 A1 20120427; AR 085663 A2 20131016; UA 94582 C2 20110525; US 9605272 B2 20170328; US 2014259221 A1 20140911; JP 6167075 B2 20170719; JP 2015006192 A 20150115; CN 104328085 A 20150204; EP 2275561 A1 20110119; US 2006282915 A1 20061214; US 7632985 B2 20091215; US 2006282911 A1 20061214; US 2006288447 A1 20061221; US 7608761 B2 20091027; WO 2006130436 A2 20061207; WO 2006130436 A8 20071227; WO 2006130436 A3 20070329; WO 2006130494 A2 20061207; WO 2006130494 A3 20070607; WO 2006128095 A2 20061130; WO 2006128095 A3 20071206; UY 29570 A1 20061229; CN 101252831 A 20080827; CN 101252831 B 20160127; CN 101253268 A 20080827; CN 101316513 A 20081203; JP 2008545413 A 20081218; JP 5631544 B2 20141126; MX 2007014970 A 20080215; MX 2007014971 A 20080212; MX 2007014972 A 20080215; BR PI0610088 A2 20081209; RU 2007149328 A 20090710; RU 2411720 C2 20110220; ZA 200710175 B 20081029; ZA 200710177 B 20081029; US 8053184 B2 20111108; US 2010099859 A1 20100422; US 8754289 B2 20140617; US 2010100980 A1 20100422; NZ 563718 A 20100730; BR PI0610051 A2 20100525; BR PI0610654 A2 20100713; BR PI0610654 B1 20170328; AP 2693 A 20130716; AP 2007004272 A0 20071231; AR 053496 A1 20070509; AR 054052 A1 20070530; AR 053497 A1 20070509; AU 2006252680 A1 20061207; AU 2006252680 A2 20080731; AU 2006252801 A1 20061207; AU 2006252801 C1 20130905; AU 2006252801 B2 20110512; CA 2609854 A1 20061130; CA 2609854 C 20120424; CA 2609418 A1 20061207; CA 2609418 C 20130903; CA 2609777 A1 20061207; EP 1883303 A2 20080206; EP 1883303 B1 20140115; EP 1885861 A2 20080213; EP 1885176 A2 20080213; EP 1885176 B1 20160824; KR 20080050548 A 20080609; KR 101076095 B1 20111021 | 97 |
| 3 | Spatially distinguished, multiplex nucleic acid analysis of biological specimens (11299774) |
Illumina Inc(US, CA, San Diego); Spatial Transcriptomics AB(SE, Stockholm) | EP 4119677 C0 20230628; EP 4119677 B1 20230628; EP 4119677 A1 20230118; EP 4151748 A1 20230322; US 11613773 B2 20230328; US 2022298560 A1 20220922; DK 3901281 T3 20230123; ES 2935860 T3 20230313; FI 3901281 T3 20230131; US 2023183785 A1 20230615; US 11390912 B2 20220719; US 2022195505 A1 20220623; US 11299774 B2 20220412; US 2022002791 A1 20220106; CN 113186256 A 20210730; US 2021292748 A1 20210923; US 11162132 B2 20211102; US 2021292822 A1 20210923; DK 3530752 T3 20210426; EP 3901281 B1 20221123; EP 3901281 A1 20211027; EP 3901282 C0 20230628; EP 3901282 B1 20230628; EP 3901282 A1 20211027; US 2020399687 A1 20201224; HK 1250245 A1 20181207; US 10774374 B2 20200915; US 2019203275 A1 20190704; EP 3530752 B1 20210324; EP 3530752 A1 20190828; JP 2018510662 A 20180419; JP 6828007 B2 20210210; CN 107532207 A 20180102; CN 107532207 B 20210507; CA 2982146 A1 20161013; SG 11201707515S A 20171030; WO 2016162309 A1 20161013; EP 3280820 A1 20180214; EP 3280820 B1 20190626 | 82 |
| 4 | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers (10377802) |
IMMATICS BIOTECHNOLOGIES GMBH(DE, Tuebingen) | SG 10202003124T A 20200528; CR 20200516 A 20201204; CR 20200515 A 20201217; AU 2021201108 A1 20210311; AU 2021201107 A1 20210311; JP 2021119773 A 20210819; JP 2021119772 A 20210819; JP 2021126114 A 20210902; MA 45424 A 20190501; TW I776245 B 20220901; TW 202124423 A 20210701; SG 11201801344S A 20180427; CA 3001074 A1 20170413; AU 2016335177 A1 20180412; AU 2016335177 B2 20201126; KR 20180055826 A 20180525; CO 2018003659 A2 20180710; CR 20180191 A 20180705; CL 2018000780 A1 20180601; MX 2018004140 A 20180606; CN 108699119 A 20181023; EA 201890635 A1 20180928; PE 20181799 A1 20181119; JP 6868010 B2 20210512; JP 2018536383 A 20181213; MA 42021 A1 20180928; US 10377802 B2 20190813; US 2019112347 A1 20190418; US 10487126 B2 20191126; US 2019119342 A1 20190425; US 10597432 B2 20200324; US 2019161526 A1 20190530; US 10654904 B2 20200519; US 2020048320 A1 20200213; GB 201517538 D0 20151118; EP 3359560 A1 20180815; WO 2017060169 A1 20170413; US 10253077 B2 20190409; US 2017096461 A1 20170406 | 73 |
| 5 | Spatially encoded biological assays (10914730) |
Prognosys Biosciences, Inc.(US, CA, San Diego) | US 11067567 B2 20210720; US 2021130884 A1 20210506; US 11156603 B2 20211026; US 2021270822 A1 20210902; US 2022404343 A1 20221222; HU E026666 T2 20160728; HK 1222210 A1 20170623; US 10662467 B2 20200526; US 2019177778 A1 20190613; US 10480022 B2 20191119; US 2019177777 A1 20190613; US 10472669 B2 20191112; US 2019271030 A1 20190905; US 2019300943 A1 20191003; US 2019300944 A1 20191003; US 10996219 B2 20210504; US 2019309353 A1 20191010; US 2019309355 A1 20191010; US 10494667 B2 20191203; US 2019309354 A1 20191010; US 2019323071 A1 20191024; PL 2556171 T3 20160429; US 10662468 B2 20200526; US 2020048690 A1 20200213; US 10982268 B2 20210420; US 2020063195 A1 20200227; US 10612079 B2 20200407; US 2020063196 A1 20200227; US 2020140934 A1 20200507; US 10619196 B1 20200414; US 2020140935 A1 20200507; US 10914730 B2 20210209; US 2020208205 A1 20200702; US 10962532 B2 20210330; US 2020208206 A1 20200702; US 10983113 B2 20210420; US 2020224256 A1 20200716; JP 5893607 B2 20160323; JP 2013523151 A 20130617; KR 101866401 B1 20180611; KR 20130100051 A 20130909; DK 2556171 T3 20151214; PT 2556171 E 20151221; ES 2555106 T3 20151229; SM T201500301 B 20160225; SI 2556171 T1 20160331; CN 105385756 A 20160309; CN 105385756 B 20201225; HR P20151294 T1 20160311; RS 54482 B1 20160630; HK 1182143 A1 20131122; US 2016298180 A1 20161013; US 10308982 B2 20190604; US 9371598 B2 20160621; US 2011245111 A1 20111006; WO 2011127099 A1 20111013; EP 2556171 B1 20150902; EP 2556171 A4 20140212; EP 2556171 A1 20130213; AU 2011237729 B2 20140403; AU 2011237729 A1 20121025; CN 102834526 B 20151202; CN 102834526 A 20121219; CA 2794522 A1 20111013; CA 2794522 C 20191126 | 71 |
| 6 | Combinatorial photo-controlled spatial sequencing and labeling (10633648) |
UNIV WASHINGTON(US, WA, Seattle) | US 2023014658 A1 20230119; US 11421221 B2 20220823; US 2020291389 A1 20200917; US 2017233722 A1 20170817; US 10633648 B2 20200428 | 67 |
| 7 | Spatially distinguished, multiplex nucleic acid analysis of biological specimens (11390912) |
ILLUMINA INC(US, CA, San Diego); Spatial Transcriptomics AB(SE, Stockholm) | EP 4119677 C0 20230628; EP 4119677 B1 20230628; EP 4119677 A1 20230118; EP 4151748 A1 20230322; US 11613773 B2 20230328; US 2022298560 A1 20220922; DK 3901281 T3 20230123; ES 2935860 T3 20230313; FI 3901281 T3 20230131; US 2023183785 A1 20230615; US 11390912 B2 20220719; US 2022195505 A1 20220623; US 11299774 B2 20220412; US 2022002791 A1 20220106; CN 113186256 A 20210730; US 2021292748 A1 20210923; US 11162132 B2 20211102; US 2021292822 A1 20210923; DK 3530752 T3 20210426; EP 3901281 B1 20221123; EP 3901281 A1 20211027; EP 3901282 C0 20230628; EP 3901282 B1 20230628; EP 3901282 A1 20211027; US 2020399687 A1 20201224; HK 1250245 A1 20181207; US 10774374 B2 20200915; US 2019203275 A1 20190704; EP 3530752 A1 20190828; EP 3530752 B1 20210324; JP 2018510662 A 20180419; JP 6828007 B2 20210210; CN 107532207 B 20210507; CN 107532207 A 20180102; CA 2982146 A1 20161013; SG 11201707515S A 20171030; WO 2016162309 A1 20161013; EP 3280820 A1 20180214; EP 3280820 B1 20190626 | 66 |
| 8 | Methods of determining a surgical margin and methods of use thereof (11407992) |
10x Genomics, Inc.(US, CA, Pleasanton) | WO 2021252499 A1 20211216; EP 4162074 A1 20230412; US 11407992 B2 20220809; US 2022098576 A1 20220331; US 11492612 B1 20221108; US 2022348905 A1 20221103; US 11624063 B2 20230411; US 2023056549 A1 20230223; US 2023227811 A1 20230720 | 63 |
| 9 | Methods of determining a surgical margin and methods of use thereof (11492612) |
10x Genomics, Inc.(US, CA, Pleasanton) | WO 2021252499 A1 20211216; EP 4162074 A1 20230412; US 11407992 B2 20220809; US 2022098576 A1 20220331; US 11492612 B1 20221108; US 2022348905 A1 20221103; US 11624063 B2 20230411; US 2023056549 A1 20230223; US 2023227811 A1 20230720 | 61 |
| 10 | Methods of detecting analytes (11479809) |
Spatial Transcriptomics AB(SE, Stockholm) | US 10030261 B2 20180724; US 2014066318 A1 20140306; CN 103781918 B 20180601; CN 103781918 A 20140507; CA 2832678 A1 20121018; CA 2832678 C 20210309; KR 20140024378 A 20140228; KR 101994494 B1 20190628; AU 2012241730 B2 20160811; AU 2012241730 A1 20131031; EP 2697391 A1 20140219; EP 2697391 B1 20191030; WO 2012140224 A1 20121018; GB 201106254 D0 20110525; EP 4183887 A1 20230524; EP 4206333 A1 20230705; US 2023100497 A1 20230330; CN 115896252 A 20230404; US 11479809 B2 20221025; US 2022213526 A1 20220707; US 2022090058 A1 20220324; US 11352659 B2 20220607; US 2022127659 A1 20220428; EP 3677692 A1 20200708; US 2019264268 A1 20190829; US 2019024154 A1 20190124; US 2019024153 A1 20190124; US 2019017106 A1 20190117; CN 108796058 A 20181113; CN 108796058 B 20230407; BR 112013026502 A2 20161129; RU 2603074 C2 20161120; RU 2013148909 A 20150520; NZ 616407 A 20141224; MX 340330 B 20160706; MX 2013011737 A 20140327; JP 5916166 B2 20160511; JP 2014513523 A 20140605 | 60 |
| 11 | Nucleic acid library methods (11512308) |
10x Genomics, Inc.(US, CA, Pleasanton) | AU 2021283174 A1 20230105; US 11608498 B2 20230321; US 2023033960 A1 20230202; US 2023183684 A1 20230615; WO 2021247543 A2 20211209; WO 2021247543 A3 20220106; EP 4025692 A2 20220713; US 11512308 B2 20221129; US 2022195422 A1 20220623 | 57 |
| 12 | Methods and systems for droplet-based single cell barcoding (10428326) |
10X GENOMICS, INC.(US, CA, Pleasanton) | US 11193122 B2 20211207; US 2021222158 A1 20210722; EP 4029939 C0 20230628; EP 4029939 A1 20220720; EP 4029939 B1 20230628; US 2022195420 A1 20220623; US 2020165603 A1 20200528; CN 110214186 A 20190906; US 2020024596 A1 20200123; US 2018216162 A1 20180802; US 10428326 B2 20191001; WO 2018140966 A1 20180802; EP 3545089 A4 20200805; EP 3545089 A1 20191002; EP 3545089 B1 20220309 | 56 |
| 13 | Methods and systems for sorting droplets and beads (10544413) |
10X Genomics, Inc.(US, CA, Pleasanton) | US 2020115703 A1 20200416; US 2018334670 A1 20181122; US 10544413 B2 20200128 | 53 |
| 14 | Methods and systems for analysis of chromatin (10725027) |
10X GENOMICS, INC.(US, CA, Pleasanton) | US 2021270818 A1 20210902; US 2021372998 A1 20211202; SG 11202007686V A 20200929; CN 112005115 A 20201127; US 2021102936 A1 20210408; US 10816543 B2 20201027; US 2019367966 A1 20191205; US 11255847 B2 20220222; US 2019367982 A1 20191205; US 10725027 B2 20200728; US 2019367969 A1 20191205; US 11131664 B2 20210928; US 2019361010 A1 20191128; US 11002731 B2 20210511; US 2019383798 A1 20191219; US 10928386 B2 20210223; US 2019383804 A1 20191219; WO 2019157529 A1 20190815; EP 3752832 A1 20201223 | 50 |
| 15 | Immunisation of large mammals with low doses of RNA (10487332) |
GlaxoSmithKline Biologicals SA(BE, Rixensart) | US 2020048636 A1 20200213; US 11655475 B2 20230523; US 2022056449 A1 20220224; CA 3169291 A1 20120112; US 2023123931 A1 20230420; US 2023112809 A1 20230413; US 2023113210 A1 20230413; US 2023111669 A1 20230413; US 2023136704 A1 20230504; HR P20160805 T1 20160812; DK 2591114 T3 20160829; ES 2586580 T3 20161017; SI 2591114 T1 20161028; HU E029284 T2 20170228; PT 2591114 T 20160802; CY 1117819 T1 20170517; PL 2591114 T3 20170831; WO 2012006369 A3 20120823; WO 2012006369 A2 20120112; EP 2591114 B1 20160608; EP 2591114 A2 20130515; CA 2804492 A1 20120112; US 2013149375 A1 20130613; US 10487332 B2 20191126; JP 5940064 B2 20160629; JP 2013530245 A 20130725 | 49 |
| 16 | Methods for analyzing nucleic acids from single cells (10767223) |
10X Genomics, Inc.(US, CA, Pleasanton) | US 2018080075 A1 20180322; US 10155981 B2 20181218; US 2019085392 A1 20190321; US 10240197 B1 20190326; US 2019153533 A1 20190523; US 10280459 B1 20190507; US 10337063 B1 20190702; US 2019185931 A1 20190620; US 10392662 B1 20190827; US 2019249247 A1 20190815; US 10633702 B2 20200428; US 2019300951 A1 20191003; US 2020208216 A1 20200702; US 10697013 B1 20200630; US 2020270681 A1 20200827; US 10767223 B1 20200908; US 10907207 B2 20210202; US 2020362410 A1 20201119; US 2021301338 A1 20210930; US 9102980 B2 20150811; US 2014272985 A1 20140918; EP 3029141 A1 20160608; ES 2562159 T3 20160302; US 9410149 B2 20160809; US 2016060693 A1 20160303; US 2016053303 A1 20160225; US 9410150 B2 20160809; US 2016076024 A1 20160317; EP 2467479 B1 20160106; EP 2467479 A2 20120627; WO 2011021102 A3 20110428; WO 2011021102 A2 20110224; CN 102482668 A 20120530; US 8298767 B2 20121030; US 2012135407 A1 20120531; US 2013059310 A1 20130307; US 2013220812 A1 20130829; US 8563274 B2 20131022; US 8679756 B1 20140325; US 2014073512 A1 20140313 | 49 |
| 17 | Increased nucleic-acid guided cell editing in yeast (10927385) |
Inscripta, Inc.(US, CO, Boulder) | US 2021317464 A1 20211014; US 10927385 B2 20210223; US 2020407732 A1 20201231; US 11066675 B2 20210720; US 2021130834 A1 20210506 | 48 |
| 18 | In vitro transcription methods and constructs (10465190) |
ModernaTX, Inc.(US, MA, Cambridge) | US 10465190 B1 20191105 | 48 |
| 19 | Curing for recursive nucleic acid-guided cell editing (10837021) |
Inscripta, Inc.(US, CO, Boulder) | US 10837021 B1 20201117; US 2020385744 A1 20201210; EP 3953477 A4 20220622; EP 3953477 A1 20220216; WO 2020247587 A1 20201210; US 11053507 B2 20210706; US 2021040489 A1 20210211; US 11254942 B2 20220222; US 2021310012 A1 20211007; AU 2020288623 A1 20220106; CA 3139122 C 20230425; CA 3139122 A1 20201210; CN 113939593 A 20220114; US 11634719 B2 20230425; US 2022195443 A1 20220623 | 48 |
| 20 | Zika RNA vaccines (10449244) |
ModernaTX, Inc.(US, MA, Cambridge) | US 2020368343 A1 20201126; MA 42502 A 20180530; US 2023020362 A1 20230119; ES 2937963 T3 20230403; US 2018280496 A1 20181004; US 10449244 B2 20191022; US 10702597 B2 20200707; US 2018344839 A1 20181206; US 2018344838 A1 20181206; US 2019060438 A1 20190228; US 11007260 B2 20210518; HK 1256169 A1 20190913; WO 2017015463 A2 20170126; WO 2017015463 A3 20180426; EP 3324979 A2 20180530; EP 3324979 A4 20190710; EP 3324979 B1 20221012; TW 201718638 A 20170601 | 48 |
| 21 | Sexually transmitted disease vaccines (10493143) |
ModernaTX, Inc.(US, MA, Cambridge) | MA 45209 A 20190417; US 2018289792 A1 20181011; JP 2018531290 A 20181025; US 2018296662 A1 20181018; US 10493143 B2 20191203; AU 2016342376 A1 20180607; CA 3002819 A1 20170427; EP 3364982 A2 20180829; EP 3364982 A4 20190417; WO 2017070616 A2 20170427; WO 2017070616 A3 20170727 | 47 |
| 22 | Spatially-tagged analyte capture agents for analyte multiplexing (11592447) |
10x Genomics, Inc.(US, CA, Pleasanton) | EP 4055185 A1 20220914; WO 2021091611 A1 20210514; US 11592447 B2 20230228; US 2022326251 A1 20221013; US 2023228762 A1 20230720 | 47 |
| 23 | Nucleic acid library methods (11608498) |
10x Genomics, Inc.(US, CA, Pleasanton) | AU 2021283174 A1 20230105; US 11608498 B2 20230321; US 2023033960 A1 20230202; US 2023183684 A1 20230615; WO 2021247543 A2 20211209; WO 2021247543 A3 20220106; EP 4025692 A2 20220713; US 11512308 B2 20221129; US 2022195422 A1 20220623 | 46 |
| 24 | Method for processing polynucleotide-containing samples (10364456) |
HANDYLAB, INC.(US, NJ, Franklin Lakes) | US 11441171 B2 20220913; US 2021047676 A1 20210218; US 10443088 B1 20191015; US 2019338344 A1 20191107; US 2019382825 A1 20191219; US 10494663 B1 20191203; US 10604788 B2 20200331; US 2019390255 A1 20191226; US 2015118684 A1 20150430; US 10364456 B2 20190730; WO 2006079082 A3 20070802; WO 2006079082 A2 20060727; US 8852862 B2 20141007; US 2006166233 A1 20060727; EP 1850959 A4 20140319; EP 1850959 A2 20071107 | 46 |
| 25 | Methods and systems for processing polynucleotides (10533221) |
10X GENOMICS, INC.(US, CA, Pleasanton) | US 11473138 B2 20221018; US 2020232027 A1 20200723; US 10533221 B2 20200114; US 2019085391 A1 20190321 | 46 |
| 26 | Spatially distinguished, multiplex nucleic acid analysis of biological specimens (11613773) |
ILLUMINA INC(US, CA, San Diego); Spatial Transcriptomics AB(SE, Stockholm) | EP 4119677 C0 20230628; EP 4119677 B1 20230628; EP 4119677 A1 20230118; EP 4151748 A1 20230322; US 11613773 B2 20230328; US 2022298560 A1 20220922; DK 3901281 T3 20230123; ES 2935860 T3 20230313; FI 3901281 T3 20230131; US 2023183785 A1 20230615; US 11390912 B2 20220719; US 2022195505 A1 20220623; US 11299774 B2 20220412; US 2022002791 A1 20220106; CN 113186256 A 20210730; US 2021292748 A1 20210923; US 11162132 B2 20211102; US 2021292822 A1 20210923; DK 3530752 T3 20210426; EP 3901281 B1 20221123; EP 3901281 A1 20211027; EP 3901282 C0 20230628; EP 3901282 B1 20230628; EP 3901282 A1 20211027; US 2020399687 A1 20201224; HK 1250245 A1 20181207; US 10774374 B2 20200915; US 2019203275 A1 20190704; EP 3530752 A1 20190828; EP 3530752 B1 20210324; JP 2018510662 A 20180419; JP 6828007 B2 20210210; CN 107532207 A 20180102; CN 107532207 B 20210507; CA 2982146 A1 20161013; SG 11201707515S A 20171030; WO 2016162309 A1 20161013; EP 3280820 A1 20180214; EP 3280820 B1 20190626 | 46 |
| 27 | Methods for analyzing nucleic acids from single cells (10697013) |
10X Genomics, Inc.(US, CA, Pleasanton) | US 2018080075 A1 20180322; US 10155981 B2 20181218; US 2019085392 A1 20190321; US 10240197 B1 20190326; US 2019153533 A1 20190523; US 10280459 B1 20190507; US 10337063 B1 20190702; US 2019185931 A1 20190620; US 10392662 B1 20190827; US 2019249247 A1 20190815; US 10633702 B2 20200428; US 2019300951 A1 20191003; US 2020208216 A1 20200702; US 10697013 B1 20200630; US 2020270681 A1 20200827; US 10767223 B1 20200908; US 10907207 B2 20210202; US 2020362410 A1 20201119; US 2021301338 A1 20210930; US 9102980 B2 20150811; US 2014272985 A1 20140918; EP 3029141 A1 20160608; ES 2562159 T3 20160302; US 9410149 B2 20160809; US 2016060693 A1 20160303; US 2016053303 A1 20160225; US 9410150 B2 20160809; US 2016076024 A1 20160317; EP 2467479 B1 20160106; EP 2467479 A2 20120627; WO 2011021102 A3 20110428; WO 2011021102 A2 20110224; CN 102482668 A 20120530; US 8298767 B2 20121030; US 2012135407 A1 20120531; US 2013059310 A1 20130307; US 2013220812 A1 20130829; US 8563274 B2 20131022; US 8679756 B1 20140325; US 2014073512 A1 20140313 | 46 |
| 28 | Methods of determining a surgical margin and methods of use thereof (11624063) |
10x Genomics, Inc.(US, CA, Pleasanton) | WO 2021252499 A1 20211216; EP 4162074 A1 20230412; US 11407992 B2 20220809; US 2022098576 A1 20220331; US 11492612 B1 20221108; US 2022348905 A1 20221103; US 11624063 B2 20230411; US 2023056549 A1 20230223; US 2023227811 A1 20230720 | 44 |
| 29 | Methods, compositions, and systems for capturing probes and/or barcodes (11618897) |
10x Genomics, Inc.(US, CA, Pleasanton) | EP 4121555 A1 20230125; WO 2022140028 A1 20220630; US 11618897 B2 20230404; US 2022356464 A1 20221110; US 11680260 B2 20230620; US 2023113230 A1 20230413; AU 2021409136 A1 20230629; US 2023203478 A1 20230629 | 44 |
| 30 | Simultaneous spatio-temporal measurement of gene expression and cellular activity (11624086) |
10x Genomics, Inc.(US, CA, Pleasanton) | WO 2021236929 A1 20211125; EP 4153775 A1 20230329; US 11624086 B2 20230411; US 2022090175 A1 20220324 | 44 |
| 31 | Method for processing polynucleotide-containing samples (10443088) |
HANDYLAB INC(US, NJ, Franklin Lakes) | US 11441171 B2 20220913; US 2021047676 A1 20210218; US 10443088 B1 20191015; US 2019338344 A1 20191107; US 2019382825 A1 20191219; US 10494663 B1 20191203; US 10604788 B2 20200331; US 2019390255 A1 20191226; US 2015118684 A1 20150430; US 10364456 B2 20190730; WO 2006079082 A3 20070802; WO 2006079082 A2 20060727; US 8852862 B2 20141007; US 2006166233 A1 20060727; EP 1850959 A4 20140319; EP 1850959 A2 20071107 | 44 |